← Open Payments lookup

MICHAEL PARNELL: Open Payments

NPI 1750954327 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$175 in 9 payments from 8 companies in 2025. Trend: 2023 $640 · 2024 $735 · 2025 $175

Food & beverage: $175
CompanyPaymentsAmount
ABBVIE INC.2$45
AstraZeneca Pharmaceuticals LP1$24
Takeda Pharmaceuticals U.S.A., Inc.1$22
Astellas Pharma US Inc1$19
PFIZER INC.1$19
Amgen Inc.1$16
Lilly USA, LLC1$15
Novo Nordisk Inc1$14

Products named: FARXIGA, QULIPTA, FRUZAQLA, VRAYLAR, Veozah, NURTEC ODT, REPATHA, MOUNJARO.

Industry payments across AL — which companies pay providers there.